On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

University Hospitals of the Ruhr-University of Bochum

InstitutionResearch output, impact & collaborations

University Hospitals of the Ruhr-University of Bochum is a institution indexed in ScholarIQ from OpenAlex.

What is known about University Hospitals of the Ruhr-University of Bochum?

ScholarIQrecord summary

University Hospitals of the Ruhr-University of Bochum is a research organisation in Bochum, DE. OpenAlex records 6,449 works and 312,048 citations for it. 1,482 researchers list it as their most recent affiliation.

How many works does University Hospitals of the Ruhr-University of Bochum have?

ScholarIQindexed works

University Hospitals of the Ruhr-University of Bochum has 6,449 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does University Hospitals of the Ruhr-University of Bochum have?

ScholarIQcitation count

University Hospitals of the Ruhr-University of Bochum has 312,048 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at University Hospitals of the Ruhr-University of Bochum?

ScholarIQresearcher count

University Hospitals of the Ruhr-University of Bochum has 1,482 researchers in the ScholarIQ index.

What is the average h-index at University Hospitals of the Ruhr-University of Bochum?

ScholarIQavg h-index

University Hospitals of the Ruhr-University of Bochum has an average h-index of 67.3 in OpenAlex.

What is the ROR of University Hospitals of the Ruhr-University of Bochum?

ScholarIQror

The ROR for University Hospitals of the Ruhr-University of Bochum is on the source record.

What is the OpenAlex record for University Hospitals of the Ruhr-University of Bochum?

ScholarIQopenalex

The OpenAlex for University Hospitals of the Ruhr-University of Bochum is on the source record.

What is the Wikidata of University Hospitals of the Ruhr-University of Bochum?

ScholarIQwikidata

The Wikidata for University Hospitals of the Ruhr-University of Bochum is on the source record.

Who are the most-cited researchers behind University Hospitals of the Ruhr-University of Bochum?

ScholarIQtop researchers by citations
1
Jürgen Braun · Spondyloarthritis Studies and Treatments
903 works56,065 citations
2
Ralf Gutzmer · Cutaneous Melanoma Detection and Management
753 works41,323 citations
3
Oliver T. Wolf · Stress Responses and Cortisol
782 works34,156 citations
4
Xenofon Baraliakos · Spondyloarthritis Studies and Treatments
1,020 works33,125 citations
5
Tarik Taleb · Software-Defined Networks and 5G
584 works25,479 citations

What are the most-cited papers on University Hospitals of the Ruhr-University of Bochum?

ScholarIQmost cited works
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen, Diana Miao, Bastian Schilling, Sachet A. Shukla, Christian U. Blank, Lisa Zimmer, Antje Sucker, Uwe Hillen, Marnix H. Geukes Foppen, Simone M. Goldinger, Jochen Utikal, Jessica C. Hassel, Benjamin Weide, Katharina C. Kaehler, Carmen Loquai, Peter Mohr, Ralf Gutzmer, Reinhard Dummer, Stacey Gabriel, Catherine J. Wu, Dirk Schadendorf, Levi A. Garraway
Science. 20152,998 CitationsOPEN ACCESS
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber, Sandra P. D’Angelo, David R. Minor, F. Stephen Hodi, Ralf Gutzmer, Bart Neyns, Christoph Höeller, Nikhil I. Khushalani, Wilson H. Miller, Christopher D. Lao, Gerald P. Linette, L. Thomas, Paul Lorigan, Kenneth F. Grossmann, Jessica C. Hassel, Michele Maio, Mario Sznol, Paolo A. Ascierto, Peter Mohr, Bartosz Chmielowski, Alan H. Bryce, Inge Marie Svane, Jean‐Jacques Grob, Angela M. Krackhardt, Christine E. Horak, Alexandre Lambert, Arvin Yang, James Larkin
The Lancet Oncology. 20152,674 Citations
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Mikhail Lichinitser, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Michele Maio, Alfonsus Johannes Maria van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul Lorigan, Nageatte Ibrahim, Sandrine Marréaud, Alexander C. J. van Akkooi, Stefan Suciu, Caroline Robert
New England Journal of Medicine. 20181,870 CitationsOPEN ACCESS
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
John B. Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E. Schmidt, Eduard Montanya, Jason Brett, Marcin Zychma, Lawrence Blonde
The Lancet. 20091,499 Citations
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, Antje Sucker, Elisabeth Livingstone, Livnat Jerby‐Arnon, Lisa Zimmer, Ralf Gutzmer, Imke Satzger, Carmen Loquai, Stephan Grabbe, Natalie I. Vokes, Claire A. Margolis, Jake R. Conway, Meng Xiao He, Haitham Elmarakeby, Felix Dietlein, Diana Miao, Adam Tracy, Helen Gogas, Simone M. Goldinger, Jochen Utikal, Christian U. Blank, Ricarda Rauschenberg, Dagmar von Bubnoff, Angela M. Krackhardt, Benjamin Weide, Sebastian Haferkamp, Felix Kiecker, Ben Izar, Levi A. Garraway, Aviv Regev, Keith T. Flaherty, Annette Paschen, Eliezer M. Van Allen, Dirk Schadendorf
Nature Medicine. 20191,119 CitationsOPEN ACCESS

How much of the research on University Hospitals of the Ruhr-University of Bochum is open access?

ScholarIQopen access share
75%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
17%
Bronze
42%
Closed
25%

Related on ScholarIQ

470M+ articles · 14-day free trial